首页> 外国专利> A Pharmaceutical composition comprising nateglinide,A process for their Preparation and the use of said composition for the preparation of a Medicament for the treatment of Metabolic Disorders, particularly diabetes,Or a disease or condition associated with Diabetes.

A Pharmaceutical composition comprising nateglinide,A process for their Preparation and the use of said composition for the preparation of a Medicament for the treatment of Metabolic Disorders, particularly diabetes,Or a disease or condition associated with Diabetes.

机译:包含那格列奈的药物组合物,其制备方法以及所述组合物在制备用于治疗代谢性疾病,特别是糖尿病或与糖尿病相关的疾病或病症的药物中的用途。

摘要

A Pharmaceutical composition comprising (a) 5, according to formula (1), in free form or a pharmaceutically acceptable Salt, and (b) a pharmaceutically acceptable vehicle,Where the granular composition can be in the presence of water without the need of a subsequent step of Spraying before the formation of tablets, a process for their PreparationAnd the use of said composition for the preparation of a Medicament for the treatment of Metabolic Disorders, particularly diabetes or a disease or condition associated with Diabetes.
机译:药物组合物,其包含(a)游离形式或药学上可接受的盐的式(1)5和(b)药学上可接受的媒介物,其中该颗粒状组合物可以在水的存在下而不需要在片剂形成之前的后续喷雾步骤,其制备方法以及所述组合物在制备用于治疗代谢性疾病,特别是糖尿病或与糖尿病相关的疾病或病症的药物中的用途。

著录项

  • 公开/公告号AR028299A1

    专利类型

  • 公开/公告日2003-05-07

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号AR2000P104821

  • 发明设计人

    申请日2000-09-14

  • 分类号A61K31/195;A61K9/20;A61P1/00;A61P3/04;A61P3/10;A61P9/00;A61P15/00;A61P17/00;A61P19/02;A61P19/10;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号